Metraipolis › archive › dc_22eaecd5f59c

The 5' Cap Epitranscriptome and Beyond: Natural and Engineered 5' Cap Modifications for Optimizing mRNA Therapeutics and Functional Studies — Europe PMC PMID:41619255

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41619255
DOI
10.1002/cmdc.202500826
License (as archived)
solo-consultazione
Archived
2026-11-07T04:26:47.409Z
SHA-256 of the archived text
4e5bca1687d91c24697dbeb9cf6652e9ab931823e1875d1ed1988209fb6960c3
Stable URL of this page
https://metraipolis.com/documento/dc_22eaecd5f59c

How to cite

The 5' Cap Epitranscriptome and Beyond: Natural and Engineered 5' Cap Modifications for Optimizing mRNA Therapeutics and Functional Studies — Europe PMC PMID:41619255 — Europe PMC (en), https://europepmc.org/article/MED/41619255 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_22eaecd5f59c (Metraipolis archive dc_22eaecd5f59c, sha256 4e5bca1687d91c24697dbeb9cf6652e9ab931823e1875d1ed1988209fb6960c3)
BibTeX
@misc{dc22eaecd5f59c,
  title = {The 5' Cap Epitranscriptome and Beyond: Natural and Engineered 5' Cap Modifications for Optimizing mRNA Therapeutics and Functional Studies — Europe PMC PMID:41619255},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41619255},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_22eaecd5f59c; sha256 4e5bca1687d91c24697dbeb9cf6652e9ab931823e1875d1ed1988209fb6960c3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41619255. Agents can read the archived copy with the MCP tool read_document.